ACADIA Pharmaceuticals Inc (ACAD) valuation · P/E 8.8, rev $1.07B
ACADIA Pharmaceuticals Inc (ACAD) P/E 8.8, rev $1.07B.
| Metric | Value |
|---|---|
| P/E | 8.8 |
| Market cap | $3.51B |
| Revenue | $1.07B |
| P/S | 3.3 |
ACAD valuation FAQ
What is ACAD's P/E ratio?
ACADIA Pharmaceuticals Inc (ACAD) trailing P/E is 8.8 on the latest cached fundamentals snapshot.
What is ACAD's market cap?
ACADIA Pharmaceuticals Inc (ACAD) market cap is $3.51B on the latest cached fundamentals snapshot.
What is ACAD's latest revenue?
Latest cached ACADIA Pharmaceuticals Inc (ACAD) revenue was $1.07B. Statements: https://lician.com/financials/acad
What is ACAD's price-to-sales ratio?
ACADIA Pharmaceuticals Inc (ACAD) price-to-sales (P/S) is 3.3, cached market cap $3.51B divided by revenue $1.07B.
How many ACAD valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for ACADIA Pharmaceuticals Inc (ACAD): P/E, Market cap, Revenue, and P/S.
Where is ACAD valuation listed?
Cached valuation multiples for ACADIA Pharmaceuticals Inc (ACAD) are listed at https://lician.com/valuation/acad.
Not investment advice. Cached rows, not a live tape.